Results 211 to 220 of about 326,761 (272)
A case report of a novel approach to the management of refractory coronary vasospasm. [PDF]
Lapin D, Arronis C, Jepson N.
europepmc +1 more source
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch +9 more
wiley +1 more source
Predicting Occlusion Myocardial Infarctions in the Emergency Department Using Artificial Intelligence. [PDF]
Nyström A +7 more
europepmc +1 more source
Abstract The oral, small molecule inhibitor of activin receptor‐like kinase‐2, zilurgisertib (INCB000928), is under evaluation in fibrodysplasia ossificans progressiva. Cardiac safety was assessed using electrocardiogram (ECG) parameters and a plasma concentration‐heart rate‐corrected QT (C‐QTc) interval analysis of pooled data from single ascending ...
Yan‐ou Yang +5 more
wiley +1 more source
Darting Waves and Diagnostic Twists: Rare "Dome and Dart" Electrocardiogram Pattern. [PDF]
Mehta S, Quealy K, Nasser MF.
europepmc +1 more source
Abstract This single‐center, randomized, open‐label bioequivalence program compared two fixed‐dose combination (FDC) tablets containing ibuprofen (200 mg) and phenylephrine hydrochloride (10 mg) from different manufacturers in healthy Chinese adults under fasting and fed conditions. A three‐period, partially replicated crossover design was used for the
Menghan Ye +8 more
wiley +1 more source
A narrative review of electrocardiogram manifestation of myocardial infarction with non-obstructive coronary arteries (MINOCA). [PDF]
Raul A +9 more
europepmc +1 more source

